NCT02215148View on ClinicalTrials.gov

Pharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients

TerminatedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Brain InjuryHyponatremia
Interventions
DRUG

Tolvaptan

Trial Locations (3)

27599

University of North Carolina Hospitals, Chapel Hill

29425

Medical University of South Carolina, Charleston

63110

Barnes-Jewish Hospital, St Louis

Sponsors
All Listed Sponsors
collaborator

Otsuka America Pharmaceutical

INDUSTRY

collaborator

Medical University of South Carolina

OTHER

collaborator

Barnes-Jewish Hospital

OTHER

lead

University of North Carolina, Chapel Hill

OTHER